Sample 144

Evaluation Instructions

Important: Models were tasked with extracting evidence from documents. Some outputs may be low quality and should be scored accordingly.

Your task: Compare the model-generated prediction (right panel) against the ground truth criteria (left panel).

Clean view: Shows formatted, readable text for easy comparison
Diff view: Highlights differences between ground truth and prediction
Raw view: Shows original unformatted text as it appears in the dataset

Evaluation scale (0-4):

0 = No match: Prediction is unrelated or contradicts the target criteria
1 = Poor match: Minimal overlap with ground truth, major errors or omissions
2 = Partial match: Some key elements captured, but notable gaps or inaccuracies
3 = Good match: Most elements correct, minor differences or formatting issues
4 = Excellent match: Essentially identical content, fully correct capture

Consider both content accuracy and completeness. Some predictions may be technically "correct" but incomplete or out of order.

Ground Truth

INCLUSION CRITERIA

  1. Aged 12 to <18 years
  2. Parent or legal guardian must provide written informed consent
  3. Treatment naïve or experienced children with genotype 1 or 4 HCV infection, and are on a maintenance cancer chemotherapy regimen
  4. Receiving a protocol-approved maintenance chemotherapy regimen for a hematological malignancy
  5. Chronic HCV infection (≥ 6 months) documented by medical history or liver biopsy
  6. Screening laboratory values within defined thresholdsNo History of solid organ or bone marrow transplantationNo history of clinical hepatic decompensation (eg, ascites, jaundice, encephalopathy, variceal hemorrhage)NOTE: Other protocol defined Inclusion/

EXCLUSION CRITERIA

  1. may apply.

Prediction

INCLUSION CRITERIA

  1. Aged 12 to <18 years
  2. Parent or legal guardian must provide written informed consent
  3. Treatment naïve or experienced children with genotype 1 or 4 HCV infection, and are on a maintenance cancer chemotherapy regimen
  4. Receiving a protocol-approved maintenance chemotherapy regimen for a hematological malignancy
  5. Chronic HCV infection (≥ 6 months) documented by medical history or liver biopsy
  6. Screening laboratory values within defined thresholds
  7. No history of solid organ or bone marrow transplantation
  8. No history of clinical hepatic decompensation (e.g., ascites, jaundice, encephalopathy, variceal hemorrhage)
  9. Must have an absolute lymphocyte count ≥ 300/mm3
  10. Must not have any Grade 3 or greater rash associated with constitutional symptoms
  11. Must not have any Grade 4 adverse event or laboratory abnormality assessed as related to the investigational drug